Verge CF - Search Results

1

Gianani R, Rabin DU, Verge CF, Yu L, Babu SR, Pietropaolo M, Eisenbarth GS. Gianani R, et al. Among authors: verge cf. Diabetes. 1995 Nov;44(11):1340-4. doi: 10.2337/diab.44.11.1340. Diabetes. 1995. PMID: 7589834

2

Autoantibodies Directed Toward a Novel IA-2 Variant Protein Enhance Prediction of Type 1 Diabetes.

Acevedo-Calado MJ, Pietropaolo SL, Morran MP, Schnell S, Vonberg AD, Verge CF, Gianani R, Becker DJ, Huang S, Greenbaum CJ, Yu L, Davidson HW, Michels AW, Rich SS, Pietropaolo M; Type 1 Diabetes TrialNet Study Group. Acevedo-Calado MJ, et al. Among authors: verge cf. Diabetes. 2019 Sep;68(9):1819-1829. doi: 10.2337/db18-1351. Epub 2019 Jun 5. Diabetes. 2019. PMID: 31167877 Free PMC article.

3

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.

Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS. Verge CF, et al. Diabetes. 1998 Dec;47(12):1857-66. doi: 10.2337/diabetes.47.12.1857. Diabetes. 1998. PMID: 9836516

4

Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes.

Verge CF, Gianani R, Yu L, Pietropaolo M, Smith T, Jackson RA, Soeldner JS, Eisenbarth GS. Verge CF, et al. Diabetes. 1995 Oct;44(10):1176-9. doi: 10.2337/diab.44.10.1176. Diabetes. 1995. PMID: 7556954

5

The design of trials for prevention of IDDM.

Eisenbarth GS, Verge CF, Allen H, Rewers MJ. Eisenbarth GS, et al. Among authors: verge cf. Diabetes. 1993 Jul;42(7):941-7. doi: 10.2337/diab.42.7.941. Diabetes. 1993. PMID: 7646584

6

Prediction and prevention of type I diabetes.

Eisenbarth GS, Gianani R, Pugliese A, Verge CF, Pietropaolo M. Eisenbarth GS, et al. Among authors: verge cf. Transplant Proc. 1994 Apr;26(2):361-2. Transplant Proc. 1994. PMID: 8171463 Review. No abstract available.

7

Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.

Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS. Verge CF, et al. Diabetes. 1996 Jul;45(7):926-33. doi: 10.2337/diab.45.7.926. Diabetes. 1996. PMID: 8666144

8

Strategies for preventing type I diabetes mellitus.

Verge CF, Eisenbarth GS. Verge CF, et al. West J Med. 1996 Mar;164(3):249-55. West J Med. 1996. PMID: 8775937 Free PMC article. Review.

9

Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes.

Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Chase HP, Eisenbarth GS. Verge CF, et al. J Autoimmun. 1996 Jun;9(3):379-83. doi: 10.1006/jaut.1996.0051. J Autoimmun. 1996. PMID: 8816974

10

Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs.

Kawasaki E, Yu L, Gianani R, Verge CF, Babu S, Bonifacio E, Eisenbarth GS. Kawasaki E, et al. Among authors: verge cf. J Clin Endocrinol Metab. 1997 Feb;82(2):375-80. doi: 10.1210/jcem.82.2.3723. J Clin Endocrinol Metab. 1997. PMID: 9024221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters